Delivery Order SPE2DB24D3013-SPE2DB25FFKZK

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $37,640.12 Firm Fixed Price Delivery Order, is for the supply of 4,567,944,238 units of the medication Teriparatide 560mcg/2.24ml Pen 2.24ml. The contract has an ultimate completion date of April 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,446.15 award is for the supply of 4,567,999,513 units of the medication Teriparatide 560mcg/2.24ml pen with a 2.24ml volume. The contract has an ultimate completion date of April 23, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,943,582 units of the medication teriparatide 560mcg/2.24ml pen, with a ceiling value of $11,646.66 and a performance period through April 17, 2025. The contract is not set aside and was awarded on April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,289.24, is for the delivery of 4,567,969,223 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,630,664 units of teriparatide 600 mcg/2.4 ml pen 2.4 ml, a specialty medication used in the treatment of certain medical conditions. The contract has a firm fixed price of $7,705.99 and a performance period ending on May 17, 2024. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,805.57, is for the delivery of 4,567,488,173 units of Teriparatide 600 mcg/2.4 ml pen with a completion date of March 7, 2025. This is a firm fixed price delivery order contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Teriparatide 600 mcg/2.4 ml pens. The contract has a ceiling value of $1,746.58 and runs through March 3, 2025. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,947.18, is for the delivery of 4,567,955,867 units of the medication teriparatide 620 mcg/2.48 ml. The contract has an ultimate completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,197,739 units of the medication teriparatide 620 mcg/2.48 ml, with a total ceiling value of $2,146.66. The contract is a firm fixed-price delivery order with a completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $2,591.28, is for the delivery of teriparatide 600 mcg/2.4 ml pens. The contract is a firm fixed-price delivery order that was awarded without the use of a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFKZK
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,722.65, is for the supply of 4,567,957,364 units of the medication Teriparatide 560mcg/2.24ml Pen 2.24ml. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 18, 2025. This order is not set aside for any specific business category.

AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 2:34 PM